Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits?
Constantin N. Baxevanis
Abstract
Immune checkpoint inhibitors (ICIs) are in the spotlight of cancer treatment by increasing the probability for long-term survival in patients with metastatic disease and by considerably prolonging progression-free survival in patients at early disease stages [...].
Topics & Concepts
MedicineImmune checkpointImmune systemDiseaseImmunotherapyCancerOncologyCancer therapyOverall survivalInternal medicineImmunologyCancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology ResearchLung Cancer Treatments and Mutations